Exogenus Therapeutics
Promoting development and commercialization of extracellular vesicles and other nanoparticles to tackle major healthcare challenges
Exogenus Therapeutics Chooses Lonza to Develop a GMP-Compliant Process to Manufacture Exo-101, its Lead Exosome-Based Candidate
Collaborative R&D
Unlock Innovation Through Collaborative R&D
Together, we can accelerate development, share expertise, and create the technologies of the future.
Pipeline
Explore the progress of our innovations, from discovery to clinical development
Our Team
Get to Know the Faces behind Exogenus Therapeutics
IP & Publications
Science First!
We believe that impactful discoveries should be open and transparent.
latest news
Exogenus Therapeutics Chooses Lonza to Develop a GMP-Compliant Process to Manufacture Exo-101, its Lead Exosome-Based Candidate Lonza to develop a GMP-compliant process for Exo-101 manufacturing...
We are pleased to announce that ExogenusTherapeutics has been granted another patent in Japan! This is the second patent granted in this region, and the first one to be granted within the family...
Joana Correia, Founder and CEO of Exogenus Therapeutics, will be a featured speaker at Exosomes Europe, taking place in London on June 5th and 6th. Joana will present a talk titled "Extracellular...
CENTRO-01-02B7-FEDER-070018
Co-financed by:
